Importantly, none of the protein kinases or transcription factors Thrombin Receptor Activator Peptide 6 biological activity reached statistical significance in association with antibodyregulated genes. Comparing overlaps among Filgotinib differentially regulated genes, we find genes specifically suppressed by the antibodies, while 112 are suppressed in common with the kinase inhibitors. Focusing on these two sets, we find that the ontological categories suppressed only by the antibodies are associated with developmental processes, specifically with a epidermis/hair, b reproduction/ovulation and vasculature/blood development. These results are quite unexpected and point, on one hand, to serious side-effects of EGFR-targeting therapies and on the other underline the importance of EGFR signaling in the homeostasis of these selfrenewing tissues. The suppressed processes in common with the kinase inhibitors comprise migration and responses to steroid hormone; the induced ones include apoptosis regulation, but, importantly, we caution that the enrichment scores are low, which precludes making confident conclusions. This work demonstrates the advantage of metaanalysis over single studies: metaanalysis provided times more regulated genes than the largest single study. Importantly, coherent, single platform metaanalysis has advantages over an assortment of platforms, but in general analyses of large data sets provide more regulated genes than of smaller ones. Because we used free, publically available metaanalysis programs, this work can serve as a paradigm for integration and metaanalysis of transcriptional data in public repositories. Large lists of regulated genes allowed us to identify novel ontological categories affected by EGFR inhibition. As expected, the suppressed genes are associated with cell-cycle, migration, transcription and protein synthesis, while the induced genes include ones associated with apoptosis, and inhibition of transcription and translation. Unexpectedly, the induced categories also include genes associated with lysosome and with steroid hormone receptor activity. The induction of lysosomal genes by EGFR inhibition is a component of the autophagy, a process commonly associated with EGFR inhibition. The induction of lysosomal genes may also play a significant role in, reducing the effectiveness of the inhibitors by degradation. Separate analyses of kinase inhibitors and antibodies identified important differences and commonalities. For example, antibodies suppress cell migration genes, much less the cell-cycle genes, while the reverse is true for kinase inhibitors. The differences do not derive from differences in cell types targeted, i.e., muscle or neuronal, they seem to be specific consequences of using different agents to inhibit EGFR. The molecular mechanisms causing thes
